emedastine has been researched along with Leukemia, Myeloid in 1 studies
emedastine: structure given in first source
emedastine : 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the difumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JL | 1 |
| Kang, HN | 1 |
| Kang, MH | 1 |
| Yoo, YA | 1 |
| Kim, JS | 1 |
| Choi, CW | 1 |
1 other study available for emedastine and Leukemia, Myeloid
| Article | Year |
|---|---|
The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Benzoates; Caspases; Cell Cycle; Cell Pro | 2011 |